Growth inhibition of human multiple myeloma cells by the CD40 ligand GP39.

被引：0
作者：
Tong, AW [1 ]
Seamour, BK [1 ]
Ordonez, G [1 ]
Stone, MJ [1 ]
机构：
[1] BAYLOR UNIV,MED CTR,CHARLES SAMMONS CANC CTR,DALLAS,TX 75246
来源：
BLOOD | 1995年 / 86卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：225 / 225
页数：1
相关论文
共 50 条
[21]   GROWTH OF NORMAL HUMAN B-LYMPHOCYTES IN-VITRO - THE ROLE OF IL-14 AND THE CD40 LIGAND GP39 [J].
AMBRUS, J ;
YOSHIMURA, L ;
TAMAYO, A ;
LEDBETTER, J ;
ARUFFO, A ;
HOLLENBAUGH, D ;
BLUMENTHAL, D ;
WEST, R ;
FORD, R .
FASEB JOURNAL, 1994, 8 (05) :A1012-A1012
[22]   Expression of CD40 and CD40 ligand in the human conjunctival epithelium [J].
Bourcier, T ;
De Saint-Jean, M ;
Brignole, F ;
Goguel, A ;
Baudouin, C .
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (01) :120-126
[23]   INHIBITION OF HUMAN B-CELL LYMPHOMA GROWTH BY SOLUBLE RECOMBINANT HUMAN CD40 LIGAND [J].
LONGO, DL ;
FUNAKOSHI, S ;
ARMITAGE, RJ ;
FANSLOW, WC ;
MURPHY, WJ .
FASEB JOURNAL, 1995, 9 (03) :A205-A205
[24]   CD40 and the effect of anti-CD40-binding on human multiple myeloma clonogenicity [J].
Tong, AW ;
Stone, MJ .
LEUKEMIA & LYMPHOMA, 1996, 21 (1-2) :1-8
[25]   THE BIOLOGY OF THE HUMAN LIGAND FOR CD40 [J].
SPRIGGS, MK ;
FANSLOW, WC ;
ARMITAGE, RJ ;
BELMONT, J .
JOURNAL OF CLINICAL IMMUNOLOGY, 1993, 13 (06) :373-380
[26]   Inhibition of aggressive histology human B cell lymphoma growth by CD40 stimulation in vivo: A comparison of a CD40 antibody and a recombinant soluble CD40 ligand (srCD40L). [J].
Murphy, WJ ;
Asai, O ;
Hirano, A ;
Funakoshi, S ;
Fanslow, WC ;
Longo, DL .
BLOOD, 1996, 88 (10) :343-343
[27]   Dual function of the cd40 ligand (gp39) for t- and b-lymphocytes [J].
Brenner B. ;
Gulbins E. ;
Koppenhoefer U. ;
Lang F. ;
Linderkamp O. .
Pediatric Research, 1998, 44 (3) :428-428
[28]   INTERACTION BETWEEN CD40 AND ITS LIGAND GP39 IN THE DEVELOPMENT OF MURINE LUPUS NEPHRITIS [J].
MOHAN, C ;
SHI, Y ;
LAMAN, JD ;
DATTA, SK .
JOURNAL OF IMMUNOLOGY, 1995, 154 (03) :1470-1480
[29]   Classification of mutations in the human CD40 ligand, gp39, that are associated with X-linked hyper IgM syndrome [J].
Bajorath, J ;
Seyama, K ;
Nonoyama, S ;
Ochs, HD ;
Aruffo, A .
PROTEIN SCIENCE, 1996, 5 (03) :531-534
[30]   Systemic upregulation of CD40 and CD40 ligand mRNA expression in multiple sclerosis [J].
Huang, WX ;
Huang, P ;
Hillert, J .
MULTIPLE SCLEROSIS, 2000, 6 (02) :61-65
12345